olmesartan medoxomil has been researched along with Aging in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashi, M; Hiroki, J; Kunihiro, I; Matoba, T; Morikawa, K; Mukai, Y; Shimokawa, H; Takeshita, A; Talukder, HM | 1 |
Gonzalez, L; Laeis, P; PĆ¼chler, K; Schwocho, LR; Sudhop, T; von Bergmann, K | 1 |
2 other study(ies) available for olmesartan medoxomil and Aging
Article | Year |
---|---|
Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase 2; Drug Administration Schedule; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; Imidazoles; Indomethacin; Isoenzymes; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrobenzenes; Olmesartan Medoxomil; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred WKY; Renin-Angiotensin System; Sulfonamides; Superoxides; Tetrazoles; Thiazepines | 2002 |
Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil.
Topics: Aged; Aging; Antihypertensive Agents; Female; Humans; Hypertension; Imidazoles; Kidney; Liver; Male; Middle Aged; Olmesartan Medoxomil; Reference Values; Tetrazoles | 2001 |